Sugammadex 4.0 mg/kg (n=51) Neostigmine 50 μg/kg
(n=49)
Gender
    Male, n (%)
    Female, n (%)
22 (43)
29 (57)
18 (37)
31 (63)
Mean (SD) age, years 49 (11) 52 (9)
Mean (SD) weight, kg 75 (16) 80 (13)
Mean (SD) height, cm 171 (10) 169 (10)
Race, n (%)
    White
    Black
    Asian
    Other
44 (86)
3 (6)
1 (2)
3 (6)
42 (86)
2 (4)
1 (2)
4 (8)
Ethnicity, n (%)
    Hispanic/Latino
    Non-Hispanic/Latino
2 (4)
49 (96)
2 (4)
47 (96)
ASA Class, n (%)
    1
    2
    3
3 (6)
37 (73)
11 (22)
8 (16)
33 (67)
8 (16)
Type of surgerya, n (%)
Digestive system and spleen
Female genital organs Urinary system, male genital organs and retroperitoneal space
18 (35)
20 (39)

13 (25)
12 (24)
23 (47)

14 (29)
aClassified according to Nordic Medico-Statistical Committee guidelines; ASA:
American Society of Anesthesiologists.
Table 1: Summary of patient baseline characteristics (all-subjects-treated group; n=100).